Xiaotao Zhang

Qingdao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Engineering ZCIF@GSK Nanoplatform to Overcome Tumor Metabolism: LDHA Inhibition-Mediated Cuproptosis for Highly Efficient Oncotherapy.

Engineering ZCIF@GSK Nanoplatform to Overcome Tumor Metabolism: LDHA Inhibition-Mediated Cuproptosis for Highly Efficient Oncotherapy.

Journal: Advanced healthcare materials

Published: April 01, 2026

Gut-lung axis in radiation-induced lung injury: mechanisms and interventions.

Gut-lung axis in radiation-induced lung injury: mechanisms and interventions.

Journal: Frontiers in immunology

Published: February 08, 2026

A commentary on "CT-based radiomics signature of visceral adipose tissue for prediction of early recurrence in patients with NMIBC: a multicentre cohort study".

A commentary on "CT-based radiomics signature of visceral adipose tissue for prediction of early recurrence in patients with NMIBC: a multicentre cohort study".

Journal: International journal of surgery (London, England)

Published: January 24, 2026

Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study.

Real-World Treatment Patterns and Clinical Outcomes Among Chinese Patients with Stage III NSCLC: The MOOREA Study.

Journal: Targeted oncology

Published: November 07, 2025

Stereotactic Radiosurgery in Multidisciplinary Management of HER2-Positive Gastroesophageal Junction Adenocarcinoma with Large-Brain Metastases: A 9-Year Survival Case.

Stereotactic Radiosurgery in Multidisciplinary Management of HER2-Positive Gastroesophageal Junction Adenocarcinoma with Large-Brain Metastases: A 9-Year Survival Case.

Journal: Cancer management and research

Published: July 23, 2025

Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity.

Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity.

Journal: Critical reviews in oncology/hematology

Published: April 01, 2025

Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report.

Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 06, 2025

Precision treatment patterns and prognostic analysis: A retrospective study of small-cell lung cancer.

Precision treatment patterns and prognostic analysis: A retrospective study of small-cell lung cancer.

Journal: Journal of cancer research and therapeutics

Published: February 07, 2025

International experts consensus on optimal central vascular access device selection and management for patients with cancer.

International experts consensus on optimal central vascular access device selection and management for patients with cancer.

Journal: The journal of vascular access

Published: December 02, 2024

The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report.

The concomitant of non-classical stereotactic body radiotherapy with tislelizumab based on multidisciplinary modalities for leiomyosarcoma: A case report.

Journal: Medicine

Published: November 13, 2024

Global research landscape and trends of cancer stem cells from 1997 to 2023: A bibliometric analysis.

Global research landscape and trends of cancer stem cells from 1997 to 2023: A bibliometric analysis.

Journal: Medicine

Published: May 17, 2024

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.

Journal: Therapeutic advances in medical oncology

Published: January 29, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026